The choice of negative control antisense oligonucleotides dramatically impacts downstream analysis depending on the

Luca Ducoli1,2, Saumya Agrawal3,4, Chung-Chau Hon3,4

  • 1Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Vladimir-Prelog-Weg 3, 8093, Zurich, Switzerland.

BMC Genomic Data
|September 15, 2021
PubMed
Summary

Investigating long noncoding RNAs (lncRNAs) in vascular biology requires careful selection of negative control antisense oligonucleotides (ASOs). Proper controls are crucial for accurate analysis of lncRNA knockdown effects on cell transcriptomes.

Related Concept Videos